Ancient Viruses Might Be Spurring Modern-Day Cancers
By Dennis Thompson HealthDay Reporter
FRIDAY, July 19, 2024 -- Cancer growth can be fueled by flecks of ancient viral DNA lodged into the genetics of modern humans, a new study says.
Overall, about 8% of the human genome is made of bits of DNA left behind by viruses that infected our primate ancestors, researchers say.
Called “endogenous retroviruses,” these DNA fragments have long been considered harmless junk littering the modern human genetic profile, researchers said.
But new research shows that when reawakened, these ancient viral strands can help cancer survive and thrive, researchers reported July 17 in the journal Science Advances.
What’s more, shutting up these viral voices from the past can make cancer treatments more effective, researchers found.
“Our study shows that diseases today can be significantly influenced by these ancient viral infections that until recently very few researchers were paying attention to,” said senior researcher Edward Chuong.
Hes an assistant professor of molecular, cellular and developmental biology at the University of Colorado, Boulder’s BioFrontiers Institute.
Eons ago, viruses baked their DNA into humans by infiltrating sperm, eggs and embryos, shaping human evolution along the way.
While these genetic vestiges can no longer produce functional viruses, they can activate nearby human genes in ways that could affect health, researchers said.
In this study, researchers found that a specific virus called LTR10 -- which infected primates 30 million years ago -- showed surprisingly high levels of activity in several types of cancer.
LTR10 was active in about a third of tumors taken from dozens of colorectal cancer patients, researchers found. It also was very active in lung cancers.
And when researchers used gene-editing tools to cut out LRT10, they discovered that genes known to promote cancer development and growth also went dark.
“We saw that when you silence this retrovirus in cancer cells, it turns off nearby gene expression,” said lead researcher Atma Ivancevic, a research associate in Chuong’s lab.
Experiments in mice yielded similar results. Removing LTR10 from tumor cells caused cancer treatments to work better at shrinking tumors.
“We know that cancer cells express a lot of genes that are not supposed to be on, but no one really knows what is turning them on,” Chuong said in a university news release. “It turns out many of the switches turning them on are derived from these ancient viruses."
Sources
- University of Colorado, Boulder, news release, July 17, 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2024
Read this next
Current Gene Screens Miss Many at High Cancer Risk: Study
THURSDAY, July 19, 2024 -- As good as many genetic tests might be, a deeper look at the DNA of over 44,000 people identified many who carried genes that hike their risks for...
Long COVID Risk Has Declined Over the Pandemic and Vaccines May Be Key
THURSDAY, July 18, 2024 -- You're far less likely to develop Long COVID now than you were in the midst of the pandemic, promising new data shows. Changes in strains of...
Five Cases of Bird Flu Reported in Colorado Poultry Workers
MONDAY, July 15, 2024 -- Five poultry workers in Colorado have been diagnosed with bird flu, state health officials reported Sunday. "In coordination with the Colorado Department...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
